Imunon, Inc. — Director's Dealing 2014

Feb 12, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2014-02-11

Reporting Person: CHURCH JEFFREY WAYNE (CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-11	Option to Purchase Celsion Corporation Common Stock	$3.66	A	40000	Acquired	2024-02-11	Celsion Corporation Common Stock (40000)	Direct

Footnotes

F1: Represents the closing price of Celsion Corporation Common Stock on the date of grant.

F2: The option vests in thirds on February 11, 2014, February 11, 2015 and February 11, 2016.